- Asked by: Liam McArthur, MSP for Orkney Islands, Scottish Liberal Democrats
-
Date lodged: Tuesday, 28 July 2026
-
Current Status:
Answered by Tom Arthur on 13 August 2026
To ask the Scottish Government, further to the commitment in the 2026 Scottish National Party manifesto to enact a statutory price cap on essential food items, what assessment it has carried out regarding the potential impact that the policy might have on retailers’ support for good causes and community groups and programmes.
Answer
I refer the member to the answer to question S7W-01604 on 22 July 2026. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.
- Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 27 July 2026
-
Current Status:
Answered by Angela Constance on 13 August 2026
To ask the Scottish Government what its response is to reports that, as a result of a loss of oncology consultant capacity, cancer patients in NHS Highland’s catchment area will experience delays to treatment or be required to travel to another NHS board for treatment.
Answer
This is an operational decision for NHS Highland.
The Scottish Government wants people diagnosed with cancer to be treated as close to home as clinically possible. We recognise that NHS Scotland’s oncology capacity has been increasingly tested and continue to work with NHS Boards to limit the need for travel where possible and clinically appropriate.
- Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 27 July 2026
-
Current Status:
Answered by Angela Constance on 13 August 2026
To ask the Scottish Government what further support it can provide to NHS Highland to ensure its oncology department can meet local demand.
Answer
The Scottish Government convened a meeting on 24 July with Board Chief Executives and Medical Directors to discuss the current situation in NHS Highland to ensure the risks are being mitigated and the system is working collaboratively to do this.
Whilst this is an operational issue for NHS Highland the Scottish Government remains in close contact with the Health Board at this time.
- Asked by: Steven Bonnar, MSP for Uddingston and Bellshill, Scottish National Party
-
Date lodged: Tuesday, 21 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what national guidance exists for NHS boards regarding the assessment of risk and discharge planning for patients presenting with co-existing mental ill health, substance misuse and homelessness, what its position is on whether that guidance is sufficient and consistently implemented across Scotland and whether it has any plans to review or strengthen the guidance.
Answer
The Scottish Government has developed a range of national guidance, including the Discharge Without Delay approach, which promotes multidisciplinary assessment, person-centred discharge planning and collaboration between health, social care, housing and homelessness services. This approach is reinforced by Scotland's homelessness prevention duties, which, when enacted, will require relevant public bodies to ask and act where a person is at risk of homelessness and ensure housing needs are considered as part of assessment and discharge planning.
In addition, the National Mental Health and Substance Use Protocol sets expectations for joined up working between mental health and substance use services, common assessment processes, information sharing, and coordinated care pathways for people with co-occurring needs. Healthcare Improvement Scotland continues to support Health and Social Care Partnerships to support local implementation of the Protocol.
The Scottish Government will continue to work with NHS boards, local authorities and Health and Social Care Partnerships to support consistent implementation of existing guidance and consider where further improvements to national guidance and practice may be needed.
- Asked by: Amanda Lindsay, MSP for Central Scot and Lothians West, Reform UK
-
Date lodged: Thursday, 23 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what plans it has to reduce waiting times for children for neurodevelopmental assessments, including how it will ensure that CAMHS services have the staffing and resources needed to deliver timely assessments and appropriate support.
Answer
The Scottish Government is committed to improving timely access to needs-based support for children and young people, in line with GIRFEC and the National Neurodevelopmental Specification. Access to support should not be dependent on a diagnosis, except in limited circumstances such as the prescribing of ADHD medication.
We are continuing our work with COSLA and the Children and Young People’s Neurodevelopment Taskforce to deliver on the actions set out in the Review of the Specification for Children and Young People.
In 2025-26 we provided over £2.9 million of funding to support projects to improve access to neurodevelopmental support across Scotland. The 2026/27 Budget includes additional investment of £7.6 million.
It is important to recognise that CAMHS is a specialist service for those experiencing significant mental health issues. Neurodevelopmental conditions, such as autism and ADHD, are not mental health conditions. CAMHS is therefore not the correct service for neurodevelopmental diagnostic assessment, unless there is a co-occurring mental health condition that meets CAMHS criteria.
- Asked by: Miles Briggs, MSP for Edinburgh and Lothians East, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 22 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government how many individuals have been prescribed methadone in each year since 2021.
Answer
The estimated number of individuals prescribed methadone nationally in each financial year since 2020/21 is presented in the following table:
Financial Year | Estimated Number of Individuals |
2020-21 | 24,128 |
2021-22 | 23,411 |
2022-23 | 22,087 |
2023-24 | 20,540 |
2024-25 | 18,006 |
These data were previously published on Scotland's Public Health Observatory (ScotPHO) website. Updates to the ScotPHO website are currently paused, and data previously published on ScotPHO will now be incorporated into the annual Opioid Substitution Therapy (OST) Report, which is planned for publication on the Public Health Scotland (PHS) website in October 2026. The forthcoming report will include methadone patient estimates up to and including financial year 2025-26.
- Asked by: Miles Briggs, MSP for Edinburgh and Lothians East, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 22 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what safeguards are in place to monitor and prevent any undue influence by the alcohol industry on public health policy relating to alcohol harm.
Answer
The Scottish Government’s approach to safeguarding alcohol policy from undue industry influence is set out in its Alcohol Framework published in 2018. The framework states that the Scottish Government will not work with the alcohol industry on health policy development, on health messaging campaigns or on provision of education in schools and beyond the school setting.
Regulated lobbying of members of the Scottish Government as well as MSPs must be recorded on the Scottish Parliament’s lobbying register, and minutes of meetings with Scottish Government Ministers, including by the alcohol industry, are retained as part of the Scottish Government’s corporate record.
- Asked by: Miles Briggs, MSP for Edinburgh and Lothians East, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 22 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government for what reason the first meeting of the group established to consider the Scottish Health Technologies Group's recommendation that lidocaine infusions, lidocaine injections and radiofrequency treatment should continue for suitable chronic pain patients, scheduled for 29 April 2026, was cancelled, and whether it will publish details of the group's leadership, membership and remit.
Answer
The meeting planned to take place on the 29 April 2026, to discuss the formation of a short life working group to look at interventions for chronic pain, was cancelled to allow full consideration of the group’s remit, methodology, and membership.
As this group has not been established, no information is available for publication concerning its leadership, membership, or remit.
- Asked by: Martyn Day, MSP for Falkirk East and Linlithgow, Scottish National Party
-
Date lodged: Tuesday, 21 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government how it will use the findings from the forthcoming Scottish Stroke Improvement Programme audit to support the delivery of equitable national 24/7 access to thrombectomy services.
Answer
The Scottish Stroke Care Audit provides invaluable information that helps drive improvements in the delivery of stroke care, including hyperacute treatment such as thrombectomy.
In particular, the measurement of thrombolysis door-to-needle times allows the Scottish Stroke Improvement Programme to work with NHS Boards to improve hyperacute stroke care pathways.
We expect NHS Boards to identify aspects of their stroke services which do not meet the Scottish Stroke Care Standards and to work to improve their standards of care locally.
- Asked by: Miles Briggs, MSP for Edinburgh and Lothians East, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 22 July 2026
-
Current Status:
Answered by Maree Todd on 13 August 2026
To ask the Scottish Government what progress has been made in implementing the Scottish Health Technologies Group's recommendation of February 2026 that lidocaine infusions, lidocaine injections and radiofrequency treatment should be available for suitable patients with chronic pain.
Answer
NHS Scotland is required to consider the Scottish Health Technologies Group's(SHTG) recommendations. Discussions are underway to understand how those recommendations can inform sustainable, consistent and effective service delivery across Scotland.
We are working with NHSScotland partners to ensure appropriate representation from both NHS services and people living with chronic pain.